IOVANCE BIOTHERAPEUTICS, INC. Impairment of Intangible Assets (Excluding Goodwill)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Impairment of Intangible Assets (Excluding Goodwill) of $160.04 thousand for the 78-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2014-05-14
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2013-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2013-09-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2013-06-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2013-03-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2013 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2011 was $160.04K.
- IOVANCE BIOTHERAPEUTICS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2010 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month | Impairment of Intangible Assets (Excluding Goodwill) 51 month | Impairment of Intangible Assets (Excluding Goodwill) 54 month | Impairment of Intangible Assets (Excluding Goodwill) 57 month | Impairment of Intangible Assets (Excluding Goodwill) 60 month | Impairment of Intangible Assets (Excluding Goodwill) 63 month | Impairment of Intangible Assets (Excluding Goodwill) 66 month | Impairment of Intangible Assets (Excluding Goodwill) 69 month | Impairment of Intangible Assets (Excluding Goodwill) 72 month | Impairment of Intangible Assets (Excluding Goodwill) 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $160.04K 10-Q · filed 2014-05-14 | ||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 | $160.04K 10-K · filed 2014-03-28 | ||||||||
| 2013-09-30 | $0.00 derived: 10-Q 72 month − 10-Q 69 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 derived: sum of 3 quarters · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2014-03-28 | $160.04K 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | $0.00 derived: 10-Q 69 month − 10-Q 66 month · filed 2013-10-23 | $0.00 derived: sum of 2 quarters · filed 2013-10-23 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 derived: sum of 4 quarters · filed 2014-03-28 | $160.04K 10-Q · filed 2013-10-23 | ||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-10-23 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 derived: sum of 4 quarters · filed 2014-03-28 | $160.04K 10-Q · filed 2013-10-23 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $0.00 10-K · filed 2014-03-28 | $160.04K 10-K · filed 2013-09-23 | ||||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-01-25 | $0.00 derived: sum of 2 quarters · filed 2013-01-25 | $0.00 10-Q · filed 2013-01-25 | $160.04K derived: sum of 4 quarters · filed 2013-10-23 | $160.04K 10-Q · filed 2013-01-25 | ||||||||
| 2012-06-30 | $0.00 derived: 10-Q/A 57 month − 10-Q 54 month · filed 2012-09-10 | $0.00 derived: sum of 2 quarters · filed 2013-10-23 | $160.04K derived: sum of 3 quarters · filed 2013-10-23 | $160.04K derived: sum of 4 quarters · filed 2013-10-23 | $160.04K 10-Q/A · filed 2012-09-10 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-10-23 | $160.04K derived: sum of 2 quarters · filed 2013-10-23 | $160.04K derived: sum of 3 quarters · filed 2013-10-23 | $160.04K 10-Q · filed 2012-05-15 | |||||||||
| 2011-12-31 | $160.04K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $160.04K derived: sum of 2 quarters · filed 2013-09-23 | $160.04K 10-K · filed 2013-09-23 | $160.04K 10-K · filed 2012-03-30 | |||||||||
| 2011-09-30 | $0.00 10-Q · filed 2013-01-25 | $0.00 10-Q · filed 2013-01-25 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $0.00 10-K · filed 2012-03-30 | ||||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |